You are currently viewing Psychedelic Funding Update: Q3 2024

Psychedelic Funding Update: Q3 2024

  • Post category:Analysis / Pα+

We have updated our Psychedelic Company Financing Tracker to reflect activity in Q3 2024. You can explore the interactive charts here.

2024 got off to a roaring start, with over $600M raised in the first half of the year. However, the majority of that inflow happened in Q1, with a 60% drop-off in Q2.

Q3 has seen funding slow even further, with inflows down to around $37.5M for the quarter: a 90% decrease since Q1 and a nearly 80% drop from Q2. Aside from Q4 2023, when inflows dropped to a low of just over $16M, we haven’t seen levels like this since Q1 2020.

To continue reading, please log in or join Pα+…

Join Pα+ Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.


Already a member? Log In


   Regular Bulletins covering key topics and trends in the psychedelics space
   Regular articles and deep dives across psychedelic research, policy and business
   Interviews with insiders
   Monthly interactive database and commentary on psychedelic patents
   Quick-take analysis of major developments
   A Library of primers and explainers
   Access to our full back catalogue


Learn more about Pα+